Cargando…

COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry

In a cohort of severe asthma patients, a small number of COVID-19 cases was found; none resulted in death or a very severe disease course. Use of biologics for severe allergic or severe eosinophilic asthma was not associated with a higher risk of COVID-19. https://bit.ly/3ndZmyD

Detalles Bibliográficos
Autores principales:	Hanon, Shane, Brusselle, Guy, Deschampheleire, Maud, Louis, Renaud, Michils, Alain, Peché, Rudi, Pilette, Charles, Rummens, Peter, Schuermans, Daniel, Simonis, Hélène, Vandenplas, Olivier, Schleich, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Agora
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712385/ https://www.ncbi.nlm.nih.gov/pubmed/33093115 http://dx.doi.org/10.1183/13993003.02857-2020

Ejemplares similares

Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry
por: Graff, S., et al.
Publicado: (2020)

A Belgian survey on the diagnosis of asthma–COPD overlap syndrome
por: Cataldo, Didier, et al.
Publicado: (2017)

Fraction of exhaled nitric oxide is associated with disease burden in the German Asthma Net severe asthma cohort
por: Bal, Christina, et al.
Publicado: (2022)

Instability of sputum molecular phenotypes in U-BIOPRED severe asthma
por: Kermani, Nazanin Z., et al.
Publicado: (2021)

DNA methylation modules in airway smooth muscle are associated with asthma severity
por: Perry, Mark M., et al.
Publicado: (2018)

The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference
por: Masoli, Matthew, et al.
Publicado: (2021)

Outcomes over the first two years of treatment with mepolizumab in severe asthma
por: Elsey, Lynn, et al.
Publicado: (2021)

Circadian rhythm of exhaled biomarkers in health and asthma
por: Wilkinson, Maxim, et al.
Publicado: (2019)

Predictors of severe COVID-19 in a registry-based Swedish cohort of patients with COPD
por: Stridsman, Caroline, et al.
Publicado: (2021)

Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma
por: Ierodiakonou, Despo, et al.
Publicado: (2016)

The impact of asthma on mental health and wellbeing during COVID-19 lockdown
por: Higbee, Daniel H., et al.
Publicado: (2021)

Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma
por: Busse, William W., et al.
Publicado: (2021)

Why asthma might surprisingly protect against poor outcomes in COVID-19
por: Farne, Hugo, et al.
Publicado: (2020)

Biologics may have a beneficial effect in asthma patients with COVID-19
por: Izquierdo, José L., et al.
Publicado: (2021)

Reduction in asthma admissions during the COVID-19 pandemic: consequence of public health measures in Singapore
por: Wee, Liang En, et al.
Publicado: (2021)

Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights
por: Wark, Peter A.B., et al.
Publicado: (2021)

Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·µL(−1)
por: Rabe, Klaus F., et al.
Publicado: (2022)

Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort
por: Holz, Olaf, et al.
Publicado: (2021)

Arterial hypertension and the risk of severity and mortality of COVID-19
por: Leiva Sisnieguez, Carlos Enrique, et al.
Publicado: (2020)

Potential of regulatory T-cell-based therapies in the management of severe COVID-19
por: Stephen-Victor, Emmanuel, et al.
Publicado: (2020)

Noninterventional statistical comparison of BTS and CHEST guidelines for size and severity in primary pneumothorax
por: Nikolić, Marko Z., et al.
Publicado: (2015)

Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study
por: Fan, Guohui, et al.
Publicado: (2020)

Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure
por: Brusasco, Claudia, et al.
Publicado: (2021)

Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure
por: Michalick, Laura, et al.
Publicado: (2021)

Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis
por: Tornheim, Jeffrey A., et al.
Publicado: (2022)

A predictive model for disease progression in non-severely ill patients with coronavirus disease 2019
por: Ji, Mengyao, et al.
Publicado: (2020)

Intrapulmonary shunt measured by bedside pulse oximetry predicts worse outcomes in severe COVID-19
por: Kotwica, Aleksandra, et al.
Publicado: (2021)

Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects
por: Jacobs, Merel, et al.
Publicado: (2020)

SARS-CoV-2 infections in people with primary ciliary dyskinesia: neither frequent, nor particularly severe
por: Pedersen, Eva S.L., et al.
Publicado: (2021)

Wnt5a and Wnt11 as acute respiratory distress syndrome biomarkers for severe acute respiratory syndrome coronavirus 2 patients
por: Choi, Eun Young, et al.
Publicado: (2020)

Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study
por: Motos, Anna, et al.
Publicado: (2022)

A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19
por: Singh, Dave, et al.
Publicado: (2021)

More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China
por: Guan, Lili, et al.
Publicado: (2020)

Biological Therapy of Severe Asthma and Nasal Polyps
por: Bakakos, Agamemnon, et al.
Publicado: (2022)

Ciliary dyskinesia in severe asthma is not affected by chronic mucus hypersecretion
por: Kempeneers, Céline, et al.
Publicado: (2023)

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment
por: Jevnikar, Mitja, et al.
Publicado: (2021)

Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection
por: Frija-Masson, Justine, et al.
Publicado: (2020)

Hyperventilation as one of the mechanisms of persistent dyspnoea in SARS-CoV-2 survivors
por: Motiejunaite, Justina, et al.
Publicado: (2021)

How to Choose the Right Inhaler Using a Patient-Centric Approach?
por: Cataldo, Didier, et al.
Publicado: (2022)

Standard pleural interventions are not high-risk aerosol generating procedures
por: Arnold, David T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e7jabt7q7b6oj3us2u0l1raorh